We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microchip Test Identifies Antibiotic-Resistant Bacteria

By Biotechdaily staff writers
Posted on 11 Sep 2007
A microchip test quickly and inexpensively identifies dangerous drug resistant bacteria in clinical samples.

The miniaturized microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhea-causing Escherichia coli and Salmonella, which causes food poisoning. More...


In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests also identified unique and previously unknown combinations of virulence genes, whose significance has not yet been determined.

Physicians and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, and receive the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in E. coli bacteria and 54 antimicrobial resistance genes covering all the known families of Gram-negative bacteria,” said Dr. Muna Anjum from the UK Veterinary Laboratories Agency in Addlestone (UK) where the new test was developed. "Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals, and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals.”

The microchip technology will allow scientists to search for and identify important genes from other pathogens and bacteria, such as genes that may be commercially important in industrial processes such as food processing, pharmaceutical development and waste handling.

The scientists presented their new test at the Society for General Microbiology's 161st meeting, which took place at the University of Edinburgh (Edinburgh, UK), on September 3-6, 2007.


Related Links:
University of Edinburgh
UK Veterinary Laboratories Agency in Addlestone

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.